Learn More
Invitrogen™ SARS-CoV-2 Nucleocapsid Recombinant Human Monoclonal Antibody (RMH03)

Description
This antibody is a Human-Rabbit chimeric antibody, made by fusion of the antigen binding region (variable domains of the heavy and light chains, VH and VL) of a rabbit anti-NP (2019-nCov) monoclonal antibody, with the constant domain of Human IgG1. This antibody is recognized only by an anti-Human IgG secondary antibody.
Specifications
Specifications
| Antigen | SARS-CoV-2 Nucleocapsid |
| Applications | ELISA |
| Classification | Recombinant Monoclonal |
| Clone | RMH03 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA, 50% glycerol and 0.09% sodium azide |
| Gene | N |
| Gene Accession No. | P0DTC9 |
| Gene Alias | COVID19 Nucleocapsid; COVID-19 nucleocapsid; COVID19 Spike nucleocapsid; SARS-CoV-2 N |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.